UB Paderborn / Katalog / Suche / in CDI

FP07.08 A Pan-Canadian Validation Study for the Detection of EGFR-T790M Mutations Using Circulating Tumour DNA (ctDNA) from Blood

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S206-S207

2021

Volltextzugriff (PDF)

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

The Lancet (British edition), 2009-07, Vol.374 (9683), p.39-47

2009

Volltextzugriff (PDF)

Migration of cells from the yolk sac to hematopoietic tissues after in utero transplantation of early and mid gestation canine fetuses

Transplantation, 2011-04, Vol.91 (7), p.723

2011

Volltextzugriff (PDF)

Identification of two novel mutations, L105R and C342R, in Type I Gaucher disease

Clinical genetics, 2002-03, Vol.61 (3), p.229-231

2002

Volltextzugriff (PDF)

Effect of metformin on plasma metabolite profile in the Copenhagen Insulin and Metformin Therapy (CIMT) trial

Diabetic medicine, 2018-07, Vol.35 (7), p.944-953

2018

Volltextzugriff (PDF)

Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes

Human molecular genetics, 2014-05, Vol.23 (10), p.2752-2768

2014

Volltextzugriff (PDF)

Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial

Cardiovascular diabetology, 2020-09, Vol.19 (1), p.150-150, Article 150

2020

Volltextzugriff (PDF)

HIV TAT variants differentially influence the production of glucocerebrosidase in Sf9 cells

Genetics and molecular research, 2005-01, Vol.4 (3), p.491-495

2005

Volltextzugriff (PDF)

Reporting adverse reactions and events in randomised clinical trials

Ugeskrift for læger, 2010-08, Vol.172 (35), p.2381

2010

Volltextzugriff (PDF)

Identification of two novel mutations, L105R and C342R, in Type I Gaucher disease

Clinical genetics, 2002, Vol.61 (3), p.229-231

2002

Volltextzugriff (PDF)

Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation

Human mutation, 2015-09, Vol.36 (9), p.842-850

2015

Volltextzugriff (PDF)

Absent CNKSR2 causes seizures and intellectual, attention, and language deficits

Annals of neurology, 2014-11, Vol.76 (5), p.758-764

2014

Volltextzugriff (PDF)

Development of a comprehensive approach to adult hereditary cancer testing in Ontario

Journal of medical genetics, 2023-08, Vol.60 (8), p.769

2023

Volltextzugriff (PDF)

Rare Deletions at the Neurexin 3 Locus in Autism Spectrum Disorder

American journal of human genetics, 2012-01, Vol.90 (1), p.133-141

2012

Volltextzugriff (PDF)

CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems

Journal of neurodevelopmental disorders, 2014-04, Vol.6 (1), p.9-9, Article 9

2014

Volltextzugriff (PDF)

Lessons learned: single cancer rollout experience of reflex BRCA1/2 gene mutation tumor tissue testing for patients with high-grade serous carcinoma

Gynecologic oncology, 2021-08, Vol.162, p.S197-S198

2021

Volltextzugriff (PDF)

Alpha-1-antitrypsin molecular testing in Canada: A seven year, multi-centre comparison

Clinical biochemistry, 2020-07, Vol.81, p.27-33

2020

Volltextzugriff (PDF)

P576: Recalibration of scoring metrics to assess the pathogenicity of constitutional copy number variants (CNVs)

Genetics in Medicine Open, 2024, Vol.2, p.101482, Article 101482

2024

Volltextzugriff (PDF)

P485: Evaluating novel dosage sensitivity predictors for inclusion in the classification of recurrent copy number variants

Genetics in Medicine Open, 2023, Vol.1 (1), p.100532, Article 100532

2023

Volltextzugriff (PDF)

Derivation and Characterization of Canine Embryonic Stem Cell Lines with In Vitro and In Vivo Differentiation Potential

Stem cells (Dayton, Ohio), 2009-02, Vol.27 (2), p.329-340

2009

Volltextzugriff (PDF)

Deletions in 16q24.2 are associated with autism spectrum disorder, intellectual disability and congenital renal malformation

Journal of medical genetics, 2013-03, Vol.50 (3), p.163-173

2013

Volltextzugriff (PDF)

P054: Creation of the Ontario Hereditary Cancer Research Network (OHCRN)

Genetics in Medicine Open, 2023, Vol.1 (1), p.100073, Article 100073

2023

Volltextzugriff (PDF)

Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI

American journal of physiology. Heart and circulatory physiology, 2010-07, Vol.299 (1), p.H125-H133

2010

Volltextzugriff (PDF)

A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood

JTO clinical and research reports, 2021-08, Vol.2 (8), p.100212-100212, Article 100212

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

FP07.08 A Pan-Canadian Validation Study for the Detection of EGFR-T790M Mutations Using Circulating Tumour DNA (ctDNA) from Blood

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

Migration of cells from the yolk sac to hematopoietic tissues after in utero transplantation of early and mid gestation canine fetuses

Identification of two novel mutations, L105R and C342R, in Type I Gaucher disease

Effect of metformin on plasma metabolite profile in the Copenhagen Insulin and Metformin Therapy (CIMT) trial

Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes

Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial

HIV TAT variants differentially influence the production of glucocerebrosidase in Sf9 cells

Reporting adverse reactions and events in randomised clinical trials

Identification of two novel mutations, L105R and C342R, in Type I Gaucher disease

Microdeletions of ELP4 Are Associated with Language Impairment, Autism Spectrum Disorder, and Mental Retardation

Absent CNKSR2 causes seizures and intellectual, attention, and language deficits

Development of a comprehensive approach to adult hereditary cancer testing in Ontario

Rare Deletions at the Neurexin 3 Locus in Autism Spectrum Disorder

Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures

CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems

Lessons learned: single cancer rollout experience of reflex BRCA1/2 gene mutation tumor tissue testing for patients with high-grade serous carcinoma

Alpha-1-antitrypsin molecular testing in Canada: A seven year, multi-centre comparison

P576: Recalibration of scoring metrics to assess the pathogenicity of constitutional copy number variants (CNVs)

P485: Evaluating novel dosage sensitivity predictors for inclusion in the classification of recurrent copy number variants

Derivation and Characterization of Canine Embryonic Stem Cell Lines with In Vitro and In Vivo Differentiation Potential

Deletions in 16q24.2 are associated with autism spectrum disorder, intellectual disability and congenital renal malformation

P054: Creation of the Ontario Hereditary Cancer Research Network (OHCRN)

Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI

A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood

Suchergebnisse filtern